Stage Ib | List of Frontiers open access articles

Original Research

Published on 28 Feb 2023

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma

in Thoracic Oncology

Po-Hsin Lee
Chun-Ju Chiang
Jeng-Sen Tseng
Zhe-Rong Zheng
Kun-Chieh Chen
Cheng-Hsiang Chu
Yen-Hsiang Huang
Kuo-Hsuan Hsu
Wen-Chung Lee
Tsung-Ying Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1096683

3,604 views
4 citations

Systematic Review

Published on 21 Dec 2021

Efficacy and Benefit of Postoperative Chemotherapy in Micropapillray or Solid Predominant Pattern in Stage IB Lung Adenocarcinoma: A Systematic Review and Meta-Analysis

in Thoracic Surgery

Congcong Xu
Kanghao Zhu
Dong Chen
Yuhang Ruan
Zixian Jin
Hongbin Qiu
Baofu Chen
Jianfei Shen

Frontiers in Surgery

doi 10.3389/fsurg.2021.795921

3,830 views
6 citations

Original Research

Published on 27 Jan 2022

Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer

in Thoracic Oncology

Yangyang Xu
Bing Wan
Suhua Zhu
Tianli Zhang
Jingyuan Xie
Hongbing Liu
Ping Zhan
Tangfeng Lv
Yong Song

Frontiers in Oncology

doi 10.3389/fonc.2021.784289

9,896 views
23 citations

Review

Published on 15 Jan 2024

Diagnosis, treatment, and prognosis of stage IB non-small cell lung cancer with visceral pleural invasion

in Thoracic Oncology

Zegang Ruan
Xin Zhuo
Chenyang Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1310471

7,899 views
16 citations

Original Research

Published on 28 Mar 2024

Osimertinib in the treatment of resected EGFR-mutated non-small cell lung cancer: a cost-effectiveness analysis in the United States

in Drugs Outcomes Research and Policies

Gengwei Huo
Ying Song
Wenjie Liu
Xuchen Cao
Peng Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1300183

5,036 views
6 citations

Original Research

Published on 31 Aug 2022

Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis

in Thoracic Oncology

Ke Zhou
Yaqin Zhao
Linchuan Liang
Jie Cao
Huahang Lin
Zhiyu Peng
Jiandong Mei

Frontiers in Oncology

doi 10.3389/fonc.2022.938195

3,115 views
11 citations

Original Research

Published on 06 Jan 2026

A preoperative risk scoring system for survival prediction in clinical stage IB lung adenocarcinoma: a multicenter study

in Thoracic Oncology

Kotaro Murakami
Tetsuya Isaka
Takuya Nagashima
Hiroyuki Adachi
Shunsuke Shigefuku
Noritake Kikunishi
Naoko Shigeta
Yujin Kudo
Yoshihiro Miyata
Morihito Okada

Frontiers in Oncology

doi 10.3389/fonc.2025.1712276

579 views

Original Research

Published on 08 Oct 2025

To treat or not to treat? Adjuvant chemotherapy in 46 patients with stage IB lung squamous cell carcinoma: a real-world matched analysis

in Thoracic Oncology

Botao Liang
Tingting Fu
Juntang Guo
Lianbin Zhang
Chaoyang Liang
Tao Zhang
Kai Zhao
Zhaofeng Gao
Jing Yang
Leilei Shen

Frontiers in Oncology

doi 10.3389/fonc.2025.1647649

1,600 views

Original Research

Published on 22 Jan 2021

Adjuvant Radiotherapy Improved Survival in Stage I to II Low-Grade Endometrial Stromal Sarcoma: A Retrospective Study of 152 Cases

in Radiation Oncology

Wenhui Wang
Shuai Sun
Zheng Miao
Xiaorong Hou
Fuquan Zhang
Ke Hu

Frontiers in Oncology

doi 10.3389/fonc.2020.608152

6,332 views
10 citations

Original Research

Published on 26 Jul 2021

Adjuvant Radiotherapy After Minimally Invasive Surgery in Patients With Stage IA1-IIA1 Cervical Cancer

in Gynecological Oncology

Yi-xiu Gan
Qing-hua Du
Jian Li
Ye-ping Wei
Xu-wei Jiang
Xue-mei Xu
Hai-ying Yue
Xiang-de Li
Hui-jun Zhu
Xue Ou

Frontiers in Oncology

doi 10.3389/fonc.2021.690777

3,271 views
3 citations

Original Research

Published on 05 Feb 2026

The long-term avoided recurrences and recurrence-related cost of alectinib for postoperative adjuvant therapy in Chinese patients with early-stage ALK-positive non-small cell lung cancer

in Health Economics

Xuanxuan Yan
Sijuan Zhou
Jiahao Hu
Yan Xia
Haotian He
Nick Jovanoski
Melina Arnold
Jian Hu
Pingping Song
Benyuan Jiang

Frontiers in Public Health

doi 10.3389/fpubh.2025.1571980

768 views

Original Research

Published on 11 Mar 2024

Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET/CT: a retrospective study from a single center

in Thoracic Oncology

Miao Huang
Bing Liu
Xiang Li
Nan Li
Xin Yang
Yaqi Wang
Shanyuan Zhang
Fangliang Lu
Shaolei Li
Shi Yan

Frontiers in Oncology

doi 10.3389/fonc.2024.1367200

2,049 views
1 citation

Original Research

Published on 18 Feb 2022

Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size

in Thoracic Oncology

Weijia Huang
Han-Yu Deng
Ming-Ying Lin
Kai Xu
Yu-Xiao Zhang
Chi Yuan
Qinghua Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.830470

6,243 views
27 citations

Original Research

Published on 15 May 2020

Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer

in Thoracic Oncology

Bo Hao
Lin Zhang
Tao Fan
Bohao Liu
Wenyang Jiang
Hao Hu
Qing Geng

Frontiers in Oncology

doi 10.3389/fonc.2020.00661

5,599 views
3 citations

Case Report

Published on 21 Mar 2023

Case report: Laparoscopic-assisted distal gastrectomy for gastric cancer in a patient with situs inversus totalis

in Surgical Oncology

Kaifeng Zhu
Qiang Hu
Yuanshui Sun

Frontiers in Surgery

doi 10.3389/fsurg.2023.1090910

2,588 views
3 citations

Case Report

Published on 08 Dec 2025

Rapid postoperative platelet decline in a lung adenocarcinoma with sarcomatoid differentiation and concomitant JAK2 V617F mutation: a case report

in Thoracic Oncology

Luojie Deng
Xiaoping Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1722712

665 views

Articles

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma

Efficacy and Benefit of Postoperative Chemotherapy in Micropapillray or Solid Predominant Pattern in Stage IB Lung Adenocarcinoma: A Systematic Review and Meta-Analysis

Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer

Diagnosis, treatment, and prognosis of stage IB non-small cell lung cancer with visceral pleural invasion

Osimertinib in the treatment of resected EGFR-mutated non-small cell lung cancer: a cost-effectiveness analysis in the United States

Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis

A preoperative risk scoring system for survival prediction in clinical stage IB lung adenocarcinoma: a multicenter study

To treat or not to treat? Adjuvant chemotherapy in 46 patients with stage IB lung squamous cell carcinoma: a real-world matched analysis

Adjuvant Radiotherapy Improved Survival in Stage I to II Low-Grade Endometrial Stromal Sarcoma: A Retrospective Study of 152 Cases

Adjuvant Radiotherapy After Minimally Invasive Surgery in Patients With Stage IA1-IIA1 Cervical Cancer

The long-term avoided recurrences and recurrence-related cost of alectinib for postoperative adjuvant therapy in Chinese patients with early-stage ALK-positive non-small cell lung cancer

Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET/CT: a retrospective study from a single center

Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size

Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer

Case report: Laparoscopic-assisted distal gastrectomy for gastric cancer in a patient with situs inversus totalis

Rapid postoperative platelet decline in a lung adenocarcinoma with sarcomatoid differentiation and concomitant JAK2 V617F mutation: a case report